In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …

Coronary artery obstruction is an uncommon but devastating complication of transcatheter
aortic valve replacement (TAVR). Computed tomography appears to be a sensitive but …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Objectives: The aim of this study was to compare aspirin plus clopidogrel with aspirin alone
as antithrombotic treatment following transcatheter aortic valve replacement (TAVR) for the …

Abstract Objectives: The BASILICA (Bioprosthetic or native Aortic Scallop Intentional
Laceration to prevent Iatrogenic Coronary Artery obstruction during TAVR) investigational …

Background: It is unknown whether the direct oral anticoagulant edoxaban can reduce
leaflet thrombosis and the accompanying cerebral thromboembolic risk after transcatheter …

Background Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic
stenosis can lead to embolization of debris. Capture of debris by devices that provide …

Background: Stroke remains a devastating complication of transcatheter aortic valve
replacement (TAVR), which has persisted despite refinements in technique and increased …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Abstract Objectives The REFLECT II (Randomized Evaluation of TriGuard 3 Cerebral
Embolic Protection After Transcatheter Aortic Valve Implantation) trial was designed to …